2 completed, 1 suspended. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Suspended 1 |
Follow NeuroHealing Pharmaceuticals Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of the Safety and Efficacy of Tropicamide Thin Films to Reduce Hypersalivation in Parkinson's Patients NH004 tropicamide, NH004 Placebo - Sialorrhea (Excessive Drooling) | Phase 2 | Completed | NeuroHealing Pharmaceuticals Inc. | 30 | 2013-04-01 | 2015-12-10 |
| Efficacy Study of NH001 in Vegetative State & Minimally Conscious State Following a Traumatic Brain Injury Apomorphine, Placebo - Brain Injury | Phase 2 | Suspended | NeuroHealing Pharmaceuticals Inc. | 76 | 2010-07-01 | 2017-03-31 |
| Safety and Efficacy Study of NH004 Films for Relief of Sialorrhea Symptoms in Parkinson's Disease Patients 0.3 mg tropicamide, 1 mg tropicamide, 3 mg tropicamide - Sialorrhea Secondary to Parkinson's Disease | Phase 2 | Completed | NeuroHealing Pharmaceuticals Inc. | 19 | 2008-03-01 | 2015-10-12 |
Parkinson Disease (2) · Sialorrhea (2) · Brain Injuries (1) · Brain Injuries, Traumatic (1) · Coma (1) · Persistent Vegetative State (1)
Apomorphine (1) · Tropicamide (1)
Argentina (1) · France (1) · United States (1)
Elkan R Gamzu, PhD (3) · Marcelo Merello, MD, PhD (1) · Ross D Zafonte, DO (1)